Helicobacter pylori prevalence in children influenced by non-specific antibiotic treatments

Insights

Antibiotic use in adolescents significantly impacts Helicobacter pylori (H.p.) infection rates. Previous antibiotic exposure was linked to lower H.p. prevalence, suggesting a crucial role in infection dynamics.

Area of Science:

  • Gastroenterology
  • Epidemiology
  • Microbiology

Background:

  • Helicobacter pylori (H.p.) infections are implicated in gastrointestinal ulcerations and malignancies.
  • Childhood infections are influenced by environmental factors like hygiene and socioeconomic status.

Purpose of the Study:

  • To investigate the effect of antibiotic treatment on the persistence of H.p. infection in adolescents.

Main Methods:

  • An epidemiological study was conducted among 8th-grade students in Leipzig (mean age 14.6 years).
  • Prevalence of H.p. infection was determined using a voluntary 13C-urea breath test.

Main Results:

  • The overall H.p. prevalence was 6.3% (N = 1,598).
  • Students with prior antibiotic treatment showed significantly lower H.p. prevalence (4.0%) compared to those never treated (11.1%, p < 0.001).
  • H.p. prevalence decreased with an increased number of antibiotic treatments.

Conclusions:

  • Non-H.p. specific antibiotic treatments in adolescence significantly influence H.p. prevalence.
  • H.p. persistence can fluctuate in younger individuals.
  • Antibiotic history is a critical confounder for H.p. diagnosis and epidemiological studies.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...